PAREXEL

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch PAREXEL and buy or sell other stocks, ETFs, and their options commission-free!

About PRXL

PAREXEL International Corp. engages in the provision of biopharmaceutical services. It offers clinical research and logistics, medical communications, consulting, commercialization and technology products and services for pharmaceutical, biotechnology, and medical device industries. 

CEO
Peyton R. Howell
CEOPeyton R. Howell
Employees
Employees
Headquarters
Durham, North Carolina
HeadquartersDurham, North Carolina
Founded
1983
Founded1983
Employees
Employees

PRXL Key Statistics

Market cap
4.50B
Market cap4.50B
Price-Earnings ratio
43.18
Price-Earnings ratio43.18
Dividend yield
Dividend yield
Average volume
1.21M
Average volume1.21M
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$88.10
52 Week high$88.10
52 Week low
$51.16
52 Week low$51.16

Stock Snapshot

With a market cap of 4.5B, PAREXEL(PRXL) trades at $88.08. The stock has a price-to-earnings ratio of 43.18.

PAREXEL(PRXL) stock opened on 2026-03-14 at —. The price climbed to — and dipped to —.

PAREXEL(PRXL) shares are trading with a volume of 0, against a daily average of 1.21M.

In the last year, PAREXEL(PRXL) shares hit a 52-week high of $88.10 and a 52-week low of $51.16.

In the last year, PAREXEL(PRXL) shares hit a 52-week high of $88.10 and a 52-week low of $51.16.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.